Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Mar 2014

Yamanouchi J, Hato T, Niiya T, Sato Y, Onishi S, Yasukawa M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Amino Acid Substitution
Share to Codon
Share to Epitopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to Isoantibodies

Share to Mutation

Source

Identifiers

PMID: 24533958
DOI: 10.1111/hae.12363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation.PMID 24533958Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development.Semantic proximity Read ↗

Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

A close insight to factor VIII inhibitor in the congenital hemophilia A.Semantic proximity Read ↗

Key insights to understand the immunogenicity of FVIII products.Semantic proximity Read ↗

Haemophilia A and haemophilia B: molecular insights.Semantic proximity Read ↗

Haemophilia A and haemophilia B: molecular insights.Semantic proximity Read ↗

Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinSemantic proximity Read ↗

Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.